Preparation of resveratrol containing poly (lactic-co-glycolic acid) nanoparticles and investigation of its cytotoxic effect in C6 glioma cells

被引:2
作者
Dogan, Murat [1 ]
Gurgah, Fatma Zisan [2 ]
机构
[1] Univ Sivas Cumhuriyet, Fac Pharm, Dept Pharmaceut Biotechnol, Sivas, Turkey
[2] Sivas Cumhuriyet Univ, Fac Pharm, Sivas, Turkey
来源
JOURNAL OF RESEARCH IN PHARMACY | 2022年 / 26卷 / 04期
关键词
Resveratrol; PLGA; polyvinyl alcohol; nanoparticles; cytotoxicity; TRANS-RESVERATROL; CANCER; DELIVERY; STABILITY; SOLUBILITY; SYSTEMS; DISEASE;
D O I
10.29228/jrp.189
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cancer is a complex disease involving several important changes in cell morphology that ultimately lead to tumor formulation. The biological endpoint of cancer is the uncontrolled growth and proliferation of cells. Resveratrol (RES) is a polyphenolic compound from the stilbene family, which has an important place in the treatment of cancer, which is used as a pharmaceutical and nutraceutical. Studies have shown that RES has anti-tumor effects in addition to its antioxidant, antimicrobial and anti-inflammatory effects. RES protects the body against free radicals and inhibits metabolic events that induce the proliferation of cancer cells. RES is a chemically unstable compound that has problems crossing the blood-brain barrier. Therefore, it is concluded that carrier systems containing RES should be developed in order to increase the water dispersibility of resveratrol and to increase its bioavailability when taken orally. In this way, the RES will be successfully targeted to the tumor site and the undesirable properties of the unstable, heat-sensitive RES will be improved. For this purpose, drug delivery systems prepared using synthetic polymers such as Polylactic-co-glycolic acid (PLGA) have been developed. PLGA is a biodegradable and biocompatible polymer used in areas related to human health. In this study, cell culture study of C6 glioma cells obtained from ATCC was performed and for this purpose, biocompatible nanoparticles of RES with PLGA were prepared. With the preparation of these nanoparticles, the effects of RES on cell viability and the differences in the anticancer effect on cells were evaluated with the XTT cytotoxicity study.
引用
收藏
页码:911 / 919
页数:9
相关论文
共 35 条
[1]   Cancer is a Preventable Disease that Requires Major Lifestyle Changes [J].
Anand, Preetha ;
Kunnumakara, Ajaikumar B. ;
Sundaram, Chitra ;
Harikumar, Kuzhuvelil B. ;
Tharakan, Sheeja T. ;
Lai, Oiki S. ;
Sung, Bokyung ;
Aggarwal, Bharat B. .
PHARMACEUTICAL RESEARCH, 2008, 25 (09) :2097-2116
[2]   Resveratrol modulates GSH system in C6 astroglial cells through heme oxygenase 1 pathway [J].
Arus, Bernardo Assein ;
Souza, Debora Guerini ;
Bellaver, Bruna ;
Souza, Diogo Onofre ;
Goncalves, Carlos-Alberto ;
Quincozes-Santos, Andre ;
Bobermin, Larissa Daniele .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2017, 428 (1-2) :67-77
[3]   Resveratrol: A review of preclinical studies for human cancer prevention [J].
Athar, Mohammad ;
Back, Jung Ho ;
Tang, Xmwel ;
Kim, Kwang Ho ;
Kopelovich, Levy ;
Bickers, David R. ;
Kim, Arianna L. .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2007, 224 (03) :274-283
[4]   Nano- and micro-encapsulated systems for enhancing the delivery of resveratrol [J].
Augustin, Mary Ann ;
Sanguansri, Luz ;
Lockett, Trevor .
RESVERATROL AND HEALTH, 2013, 1290 :107-112
[5]   Design and Optimization of PLGA-Based Diclofenac Loaded Nanoparticles [J].
Cooper, Dustin L. ;
Harirforoosh, Sam .
PLOS ONE, 2014, 9 (01)
[6]   Resveratrol encapsulation: Designing delivery systems to overcome solubility, stability and bioavailability issues [J].
Davidov-Pardo, Gabriel ;
McClements, David Julian .
TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2014, 38 (02) :88-103
[7]  
Demir D, 2013, LECT SERIES LODZ
[8]   Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity [J].
Fonseca, C ;
Simoes, S ;
Gaspar, R .
JOURNAL OF CONTROLLED RELEASE, 2002, 83 (02) :273-286
[9]   Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans [J].
Gambini, J. ;
Ingles, M. ;
Olaso, G. ;
Lopez-Grueso, R. ;
Bonet-Costa, V. ;
Gimeno-Mallench, L. ;
Mas-Bargues, C. ;
Abdelaziz, K. M. ;
Gomez-Cabrera, M. C. ;
Vina, J. ;
Borras, C. .
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2015, 2015
[10]  
Hammett R., 2018, MED CHEM, V08, P242, DOI [https://doi.org/10.4172/2161-0444.1000519, DOI 10.4172/2161-0444.1000519]